Helius Medical Technologies (NASDAQ:HSDT) Shares Down 0.7%

Helius Medical Technologies, Inc. (NASDAQ:HSDTGet Free Report)’s share price traded down 0.7% during mid-day trading on Monday . The stock traded as low as $1.35 and last traded at $1.40. 39,565 shares changed hands during trading, a decline of 91% from the average session volume of 434,706 shares. The stock had previously closed at $1.41.

Wall Street Analyst Weigh In

Separately, Roth Mkm raised their price target on Helius Medical Technologies to $24.00 and gave the company a “buy” rating in a report on Tuesday, March 5th.

Check Out Our Latest Stock Report on Helius Medical Technologies

Helius Medical Technologies Stock Down 0.7 %

The company has a 50 day simple moving average of $3.64 and a 200-day simple moving average of $5.61. The stock has a market capitalization of $3.54 million, a price-to-earnings ratio of -0.11 and a beta of 1.60.

Helius Medical Technologies (NASDAQ:HSDTGet Free Report) last released its quarterly earnings data on Monday, May 13th. The company reported ($3.08) EPS for the quarter. Helius Medical Technologies had a negative net margin of 1,328.14% and a negative return on equity of 297.49%. The firm had revenue of $0.14 million for the quarter.

About Helius Medical Technologies

(Get Free Report)

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.

Further Reading

Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.